• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血管内皮生长因子(VEGF)注射3次后视网膜新生血管形成的多模态成像特征

Multimodal imaging features of retinal neovascularization in response to 3 anti-VEGF injections.

作者信息

Parrulli Salvatore, Airaldi Matteo, Folegani Valentina, Erba Stefano, Govetto Andrea, Zicarelli Federico, Invernizzi Alessandro, Staurenghi Giovanni, Cereda Matteo G

机构信息

Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco", Sacco Hospital, University of Milan, Milan, Italy.

Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco", Sacco Hospital, University of Milan, Milan, Italy.

出版信息

Can J Ophthalmol. 2025 Aug;60(4):243-251. doi: 10.1016/j.jcjo.2024.11.001. Epub 2024 Nov 30.

DOI:10.1016/j.jcjo.2024.11.001
PMID:39622282
Abstract

OBJECTIVE

To analyze longitudinal changes of retinal neovessels (NV) in eyes with proliferative diabetic retinopathy (PDR) after 3 monthly intravitreal injections (IVI) of ranibizumab by means of different imaging modalities, particularly focusing on optical coherence tomography (OCT) and OCT-angiography (OCT-A) features.

METHODS

Prospective, monocentric study, Luigi Sacco Hospital, Milan. Consecutive patients with PDR were enrolled. All patients underwent color fundus photography (CFP), fluorescein angiography (FA), SD-OCT, and OCT-A at baseline (t0) and after 3 monthly IVI of ranibizumab (t1). Neovessels (NVs) were classified as flat, elevated, flat-elevated, or table-top using OCT scans and further analyzed on FIJI. Qualitative and quantitative NV characteristics were evaluated. Vessel density (VD) was calculated as the mean of all the white pixels of the NV and expressed as a percentage of the area of the NV (VD = NV area × 100).

RESULTS

Thirty-six NVs in 10 patients were studied. The regression of NVs at t1 was partial in 66.7% of cases and complete in 33.3%. Table-top NV demonstrated more frequently a complete regression (P = .03). A significant reduction of the NV area, perimeter, and VD was observed at t1 (P < .001). NVs that showed a complete regression had higher mean VD values at t0 compared with NVs, which showed a partial regression (P = .02). Flat NVs had more frequently a complete vitreous attachment, while table-top showed more often a partial vitreous detachment with focal NV adhesion (P < .05). A complete regression was more often observed for NVs with a partial vitreous detachment and focal NV adhesion at t0 (10/12), while most of the NVs with a complete vitreous attachment showed a partial regression (18/24) (P < .001).

CONCLUSIONS

The table-top configuration of the neovessel, higher VD values at baseline, and the presence of a focal adhesion of the vitreous over the NV were factors associated with a higher risk of complete regression of the NV in response to 3 monthly IVI of ranibizumab.

摘要

目的

通过不同成像方式分析增殖性糖尿病视网膜病变(PDR)患者在每月一次玻璃体内注射(IVI)雷珠单抗3次后的视网膜新生血管(NV)的纵向变化,尤其关注光学相干断层扫描(OCT)和OCT血管造影(OCT-A)特征。

方法

前瞻性单中心研究,米兰路易吉·萨科医院。纳入连续的PDR患者。所有患者在基线时(t0)以及每月一次IVI雷珠单抗3次后(t1)均接受彩色眼底照相(CFP)、荧光素血管造影(FA)、SD-OCT和OCT-A检查。使用OCT扫描将新生血管(NVs)分类为扁平、隆起、扁平-隆起或桌面状,并在FIJI上进一步分析。评估NV的定性和定量特征。血管密度(VD)计算为NV所有白色像素的平均值,并表示为NV面积的百分比(VD = NV面积×100)。

结果

研究了10例患者的36个NV。在t1时,66.7%的病例中NV部分消退,33.3%完全消退。桌面状NV更常表现为完全消退(P = 0.03)。在t1时观察到NV面积、周长和VD显著减少(P < 0.001)。与部分消退的NV相比,完全消退的NV在t0时平均VD值更高(P = 0.02)。扁平NV更常具有完全的玻璃体附着,而桌面状NV更常表现为部分玻璃体脱离伴局灶性NV粘连(P < 0.05)。在t0时,部分玻璃体脱离伴局灶性NV粘连的NV更常观察到完全消退(10/12),而大多数具有完全玻璃体附着的NV表现为部分消退(18/24)(P < 0.001)。

结论

新生血管的桌面状形态、基线时较高的VD值以及玻璃体在NV上的局灶性粘连是与每月一次IVI雷珠单抗3次后NV完全消退风险较高相关的因素。

相似文献

1
Multimodal imaging features of retinal neovascularization in response to 3 anti-VEGF injections.抗血管内皮生长因子(VEGF)注射3次后视网膜新生血管形成的多模态成像特征
Can J Ophthalmol. 2025 Aug;60(4):243-251. doi: 10.1016/j.jcjo.2024.11.001. Epub 2024 Nov 30.
2
Clinical and imaging characteristics associated with foveal neovascularization in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中与黄斑中心凹新生血管相关的临床和影像学特征。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):679-687. doi: 10.1007/s00417-024-06660-1. Epub 2024 Nov 15.
3
Comparable choroidal thickness between treated eyes and untreated fellow-eyes in patients with unilateral neovascular AMD: a paired-eyes comparative study.单侧新生血管性年龄相关性黄斑变性患者治疗眼与未治疗对侧眼脉络膜厚度的比较:配对眼比较研究。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 8. doi: 10.1007/s00417-025-06751-7.
4
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
5
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
6
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.抗血管内皮生长因子治疗视网膜分支静脉阻塞继发的黄斑水肿。
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009510. doi: 10.1002/14651858.CD009510.pub2.
7
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
8
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿:一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD007419. doi: 10.1002/14651858.CD007419.pub5.
9
Efficacy of anti-VEGF monotherapy versus anti-VEGF therapy with subthreshold micropulse laser (SML) in the management of diabetic macular oedema (DMO): a systematic review and meta-analysis.抗血管内皮生长因子单药治疗与亚阈值微脉冲激光(SML)联合抗血管内皮生长因子治疗糖尿病黄斑水肿(DMO)的疗效:系统评价和荟萃分析。
Graefes Arch Clin Exp Ophthalmol. 2024 Sep;262(9):2733-2749. doi: 10.1007/s00417-024-06405-0. Epub 2024 Feb 29.
10
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.